Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cells.

Lambrecht, V; Le Bourhis, X; Toillon, R A; Boilly, B; Hondermarck, H

Lambrecht, V; Le Bourhis, X; Toillon, R A; Boilly, B; Hondermarck, H.

Affiliation

Lambrecht V; Unité de Dynamique des Cellules Embryonnaires et Cancéreuses, Bâtiment SN3, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq Cedex, 59655, France.

Exp Cell Res ; 245(2): 239-44, 1998 Dec 15.

Article in En | MEDLINE | ID: mdl-9851863

Subject(s)

Cell Division/drug effects; Fibroblast Growth Factor 2/metabolism; Growth Inhibitors/pharmacology; Heparan Sulfate Proteoglycans/metabolism; Binding Sites/drug effects; Breast Neoplasms; Butyrates/pharmacology; Cell Membrane/metabolism; Cells, Cultured; Epidermal Growth Factor/pharmacology; Epithelial Cells; Female; Humans; Mitogens; Sodium/pharmacology; Transforming Growth Factor beta/pharmacology; Tretinoin/pharmacology; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cell Division / Fibroblast Growth Factor 2 / Heparan Sulfate Proteoglycans / Growth Inhibitors Limits: Female / Humans Language: En Journal: Exp Cell Res Year: 1998 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links